Advanced search
Publication Cover
Current Medical Research and Opinion Volume 37, 2021 - Issue 1
Submit an article Journal homepage
3,504
Views
3
CrossRef citations to date
0
Altmetric
Respiratory Medicine

Single inhaler triple therapy (FF/UMEC/VI) versus FF/VI and UMEC/VI in patients with COPD: subgroup analysis of the China cohort in the IMPACT trial

Jinping Zhenga State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University, Guangzhou, ChinaCorrespondence[email protected]
,
Nanshan Zhonga State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China
,
Changzheng Wangb Xinqiao Hospital, Third Military Medical University, Chongqing, China
,
Li Ping Weic Third Affiliated Hospital, Guangzhou Medical University, Guangzhou, China
,
Xiang Dong Zhoud Xinan Hospital, Third Military Medical University, Chongqing, China
,
Li Zhaoe Shengjing Hospital of China Medical University, Shenyang, China
,
Ya Dong Yuanf Respiratory Department, The Second Hospital of Hebei Medical University, Shijazhuang, China
,
Bei Heg Peking University Third Hospital, Beijing, China
,
Bin Wuh Affiliated Hospital, Guangdong Medical University, Zhanjiang, China
,
Xin DuI GSK, Shanghai, China
,
Jie SongI GSK, Shanghai, China
&
David A. Lipsonj GSK, Collegeville, PA, USA;k Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
 show all
Pages 145-155 | Received 05 Jun 2020, Accepted 12 Oct 2020, Published online: 07 Dec 2020

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.